收藏切换
Updated key points and interpretation of the Sixth International Consensus Conference for Advanced Breast Cancer focusing on the hormone receptor positive subtype
收藏切换
Shuhui JU, Hengyu LI*
World Clinical Drug | 2022, 43(4) : 347 - 351
Less
收藏切换
World Clinical Drug | 2022, 43(4): 347-351
• Recommendation •
Updated key points and interpretation of the Sixth International Consensus Conference for Advanced Breast Cancer focusing on the hormone receptor positive subtype
Full
Shuhui JU, Hengyu LI*
Affiliations
  • Department of Thyroid and Breast Surgery, Changhai Hospital, Navy Medical University, Shanghai 200433, China
Published: 2022-04-10 doi: 10.13683/j.wph.2022.04.001
Outline
收藏切换

The International Consensus Conference for Advanced Breast Cancer (ABC) is a premier international conference in breast cancer field organized by European School of Oncology (ESO) and European Society for Medical Oncology (ESMO). The conference aims to develop international consensus guidelines for the management of ABC patients, affect treatment decisions, prolong patients' overall survival, and improve patients' quality of life based on the latest evidence-based medical solutions. Breast cancer is divided into different subtypes on different hormone receptor (HR) and human epidermal growth factor receptor-2 (HER2) status. HR positive/HER2 negative breast cancer is the most common. With the emergence of various novel candidates for endocrine and targeted therapies, optimal drug selection and appropriate arrangement is critical to the prolongation of patients' survival. November 2021, the Sixth International Consensus Conference for ABC was successfully held online, which provided guidance for the clinical practice. The article reviewed the updated key points and interpretation of HR positive/HER2 negative ABC part, in order to provide reference for the medication of ABC patients.

breast cancer  /  hormone receptor positive  /  human epidermal growth factor receptor-2 negative  /  the International Consensus Conference for Advanced Breast Cancer  /  CDK4/6 inhibitor
巨淑慧, 李恒宇. 第6届晚期乳腺癌国际共识会议对激素受体阳性晚期乳腺癌的更新要点及解读. 世界临床药物, 2022 , 43 (4) : 347 -351 . DOI: 10.13683/j.wph.2022.04.001
Shuhui JU, Hengyu LI. Updated key points and interpretation of the Sixth International Consensus Conference for Advanced Breast Cancer focusing on the hormone receptor positive subtype[J]. World Clinical Drug, 2022 , 43 (4) : 347 -351 . DOI: 10.13683/j.wph.2022.04.001
Year 2022 volume 43 Issue 4
18
5
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2022.04.001
  • Receive Date:2022-02-15
  • Online Date:2026-11-19
  • Published:2022-04-10
Article Data
Affiliations
History
  • Received:2022-02-15
Affiliations
    Department of Thyroid and Breast Surgery, Changhai Hospital, Navy Medical University, Shanghai 200433, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.04.001
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT